Notice Director’s Report Management Discussion Report on Corporate Auditor’s Report
Balance Sheet Profit and Loss Notes Forming Case Flow Proxy Form

Statement of Profit & loss

COLINZ LABORATORIES LTD.

STATEMENT OF PROFIT AND LOSS  FOR THE YEAR ENDED MARCH 31, 2012

All amounts in Rupees, unless otherwise stated
 Year ended   Year ended 
NOTES  March 31, 2012   March 31, 2011 
 I  Revenue from Operations
Sales -Products 14               70,454,561                 60,336,549
Other Operating Revenue                              -                                  -
Less : Excise duty               (4,435,470)                (3,312,887)
              66,019,091                 57,023,662
 II  Other Income 15                    368,554                      221,982
 III  Total Revenue (I+II)              66,387,645               57,245,644
 IV  Expenses
Cost of Materials Consumed 16               24,417,414                 21,033,670
Purchase of Trading Goods                 3,457,117                   3,045,463
Changes in inventories of finished goods work-in-progress and Stock-in-Trade 17               (1,095,212)                (2,310,950)
Employee Benefits Expense 18               22,543,606                19,047,690
Finance Cost 19                 1,892,853                   1,560,718
Depreciation and amortization expense 6                 2,599,467                   2,577,525
Other Expenses 20               11,693,676                 11,506,788
Total Expenses              65,508,921               56,460,904
 V  Profit before exceptional and extraordinary items and tax (III-IV)                    878,724                      784,740
 VI  Exceptional items                              -                                  -
 VII  Profit before extraordinary items and tax (V - VI)                    878,724                      784,740
 VIII  Extraordinary Items                              -                                  -
 IX  Profit before tax (VII- VIII)                    878,724                      784,740
 X  Tax expense:
(1) Current tax                    158,337                      133,850
(2) Deferred tax                  (383,863)                     (77,935)
 XI  Profit (Loss) for the period from continuing operations (IX-X)                 1,104,250                      728,825
 XII  Profit/(loss) from discontinuing operations                              -                                  -
 XIII  Tax expense of discontinuing operations                              -                                  -
 XIV  Profit/(loss) from Discontinuing operations (after tax) (XII-XIII)                              -                                  -
 XV  Profit (Loss) for the period (XI + XIV)                 1,104,250                      728,825
 XVI  Earnings per equity share:
(1) Basic                          0.24                            0.16
(2) Diluted                              -  
Significant accounting policies and notes  21
 to the financial statements 

 

As per our report of even date attached

For S. V. Bhat & Co. For and on behalf of the Board of Directors
Firm Registration Number: 101298W
Chartered Accountants
S. V. Bhat Dr. L. S. Mani N. K. Menon  
Proprietor Chairman & Managing Director Director
Membership Number: 37237
Place: Mumbai
Date: 15th May,2012

 

(Top)

Contact:
A/101, Pratik Estate,
Mulund Link Road,
Next to Fortis Hospital,
Mumbai-400078.
Tel.: 91-22-25668002/3
Fax: 91-22-25668006.
Email: cllfindoc@yahoo.com
Website:www.findoc-cll.in
Email:info@findoc-cll.in